Latest Blogs

May 19, 2022
Dr. Khalid El Bairi advises early-career researchers in low- and middle-income countries to focus first on learning universal methodology, then on targeted training for specific projects.
May 17, 2022
"If we, as knowledgeable people, start informing women whom we come across about cervical cancer screening, we add a drop to the ocean of wellness," said Dr. Pesona Grace Lucksom.
May 12, 2022
Since ASCO22 will be offered as a hybrid meeting, with both an in-person and a virtual experience, we get the best of both worlds.
May 12, 2022
Ellen Zhang shares an original poem inspired by the parent-child interactions she witnessed while working with pediatric patients with cancer.
Subscribe to this column

ASCO Commentary

ASCO Commentary provides an interactive platform for ASCO’s organizational leadership and senior staff to connect directly to ASCO’s membership and the wider oncology community.

Nov 03, 2021
ASCO president Dr. Everett E. Vokes and Nominating Committee chair Dr. Sharon H. Giordano have a call to action for all voting-eligible members.
Feb 21, 2018
Dr. Richard L. Schilsky describes ASCO's Targeted Agent and Profiling Utilization Registry (TAPUR) Study and similar independent studies worldwide.
Oct 28, 2016
Dr. Richard L. Schilsky outlines the Society's Target Agent and Profiling Utilization Registry (TAPUR) Study and similar international protocols. A global data sharing platform could greatly accelerate our ability to learn about new uses for currently approved targeted anticancer drugs.
Nov 02, 2015
Chief Medical Officer Dr. Richard L. Schilsky answers your questions about this exciting new opportunity in health care policy and advocacy.
Oct 26, 2015
Personalized cancer care is not a new concept, but its application has been enabled and enhanced by a far greater understanding of the biological underpinnings of cancer than ever existed before.
Nov 12, 2014
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. During the past six weeks I’ve had the opportunity to attend cancer meetings in four countries on three continents. In September, I represented ASCO at the annual meeting of the Chinese Society of Clinical Oncology (CSCO) in Xiamen,...

Pages